(Q47575060)

4 February 2018

title

Home nebulizers: can optimal therapy be predicted by laboratory studies? (English)

1 reference

4 February 2018

author name string

O'Driscoll BR

1

1 reference

4 February 2018

Kay EA

2

1 reference

4 February 2018

Taylor RJ

3

1 reference

4 February 2018

Bernstein A

4

1 reference

4 February 2018

publication date

1 November 1990

1 reference

4 February 2018

published in

Respiratory Medicine

1 reference

4 February 2018

volume

84

1 reference

4 February 2018

issue

6

1 reference

4 February 2018

page(s)

471-477

1 reference

4 February 2018

Home nebulisers for airflow limitation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

A comparison of metered dose inhalers with nebulizers from the delivery of ipratropium bromide in domiciliary practice

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

Domiciliary nebulised salbutamol solution in severe chronic airway obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

Role of the parasympathetic system in airway obstruction due to emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

Dose response relation to oral theophylline in severe chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980111-4

7 January 2021

10.1016/S0954-6111(08)80111-4

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018